Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer

详细信息    查看全文

• 作者：David R. Gandara ; ^{drgandara@ucdavis.edu} ; Jonathan W. Riess ; Karen Kelly ; Tianhong Li ; Philip C. Mack ; Primo N. Lara Jr.
• 关键词：Epidermal growth factor receptor ; NSCLC ; Targeted therapy ; Therapeutic landscape ; Tyrosine kinase inhibitor
• 刊名：Clinical Lung Cancer
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：18
• 期：1
• 页码：1-4
• 全文大小：263 K
• 卷排序：18

文摘

The therapeutic landscape in advanced non–small-cell lung cancer (NSCLC) is rapidly changing. Never have so many changes of major importance occurred within so short a time. The present perspective describes this rapid evolution and resultant increasing complexity in the therapeutic decision-making process for the practicing oncologist.